Intracoronary versus intravenous abciximab administration in patients with ST-elevation myocardial infarction undergoing thrombus aspiration during primary percutaneous coronary intervention—Effects on soluble CD40 ligand concentrations

This publication has 33 references indexed in Scilit:

• Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
  Circulation, 2008
• Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: A meta-analysis of randomized trials
  American Heart Journal, 2007
• Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI
  International Journal of Cardiology, 2005
• Daño miocárdico por reperfusión
  Revista Espanola de Cardiologia, 2004
• Angiographic perfusion score: An angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction
  American Heart Journal, 2004
• Intracoronary Administration of Abciximab Acutely Increases Flow Through Culprit Vessels of Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
  Circulation, 2003
• 7E3 Monoclonal Antibody Directed Against the Platelet Glycoprotein IIb/IIIa Cross-reacts With the Leukocyte Integrin Mac-1 and Blocks Adhesion to Fibrinogen and ICAM-1
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Expression of functional CD40 by vascular endothelial cells.
  The Journal of Experimental Medicine, 1995
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985
• Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic Death
  New England Journal of Medicine, 1984